University of North Carolina Health CareOct 8 2024
Lagging federal funding of trials will reduce critical research in areas like cancer prevention, screening, symptom management and health disparities, said Sharpless, a professor of cancer policy and innovation at UNC School of Medicine. "To sustain progress and address these gaps, we need diversified funding and strong advocacy to ensure that all patient populations benefit from research advancements.
Related StoriesAbdou and Sharpless outlined a four-point call to action to address the growing disparity between industry and federally funded trials: 2. Diversify Funding Sources: It is imperative to explore alternative funding sources, such as state-level funding, industry-academia collaborations and philanthropy, in order to support a wider range of clinical trials.